Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

exemestane 1entinostat 1Mammography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Mammary Neoplasms, Animal × Clear all
NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Baylor College of Medicine

Phase 1 Not yet recruiting
27 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT00676663 2022-05-11

ENCORE301

Syndax Pharmaceuticals

Phase 2 Completed
130 enrolled 18 charts
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT02977247 2021-09-05

SV PCC ARM2

Delphinus Medical Technologies, Inc.

Completed
1,150 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT03257839 2021-09-05

SV PCC ARM1

Delphinus Medical Technologies, Inc.

Completed
7,409 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡